Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
04/2009
04/22/2009CN101415683A New compounds
04/22/2009CN101413143A Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
04/22/2009CN100481571C Luminescent element material and luminescent element comprising the same
04/21/2009US7521563 Hydroxamic acid derivative and medicine containing the same as active ingredient
04/21/2009US7521467 Administering phenolic derivatives including 6-methoxy-2,3-benzoxazolinone (6-MBOA), benzoxazinoids-cyclic hydroxyamic acids, lactams, and corresponding glucosides; antiarthritic, antidiabetic, and hypoglycemic agents; sleep disorders, fibromyalgia; monocotyledon plant extracts
04/21/2009CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents
04/16/2009WO2009049180A2 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
04/16/2009WO2009048874A1 Method of making ketals and acetals
04/16/2009WO2009047797A2 Process for the preparation of perhydroisoindole derivative
04/16/2009WO2009046841A2 Piperidine and piperazine derivatives for treating tumours
04/16/2009WO2009027998A3 A process for the preparation of alanine-nca (alanine-n-carboxyanhydride) from alanine with tri phosgene
04/16/2009WO2007034254A3 Amino-alkyl-amide derivatives as ccr3 receptor ligands
04/16/2009US20090099355 Processes for Production of 4-(Biphenylyl)Azetidin-2-One Phosphonic Acids
04/16/2009US20090099233 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
04/16/2009US20090099201 Diacylglycerol Acyltransferase Inhibitors
04/16/2009US20090099189 CRTH2 Receptor Ligands For Medicinal Uses
04/16/2009US20090099139 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
04/16/2009CA2701946A1 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
04/16/2009CA2701519A1 Piperidine and piperazine derivatives
04/15/2009EP1703909B1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
04/15/2009CN101410385A Benzothiazoles having histamine H3 receptor activity
04/15/2009CN101410384A Compounds and methods for modulating protein trafficking
04/15/2009CN101410375A Method for producing aromatic compound
04/15/2009CN101410373A Bridged cyanine compounds and optical recording materials containing the same
04/15/2009CN101407501A Preparation of 5-methyl morpholine-3-amino-2-oxazolidinone derivative hapten, antigen and antibody
04/14/2009US7517988 N-hydroxy-4-[2-(benzofuran-2-ylcarbonylamino)ethylsulfonyl]-benzamide; hepatitis C; inhibitors of histone deacetylase
04/14/2009US7517896 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis
04/14/2009CA2138533C Drugs that enhance synaptic responses mediated by ampa receptors
04/09/2009WO2009043889A2 Oxadiazole derivatives
04/09/2009WO2009004141A3 Method for preparing enantiomerically enriched n-carboxyanhydride
04/09/2009US20090093497 Diacylglycerol Acyltransferase Inhibitors
04/09/2009US20090093451 IL-8 Receptor Antagonists
04/09/2009US20090091252 Binaphthyl compound and organic light emitting element using the same
04/09/2009US20090091234 Room temperature molten salt and display element
04/09/2009CA2696863A1 Oxadiazole derivatives
04/08/2009EP2045238A1 Bridged cyanine compounds and optical recording materials containing the same
04/08/2009EP2044040A2 1,3-oxazole derivatives useful as anti-atherosclerotic, anti-dyslipidemic, anti-diabetic and anti-obesity agents
04/08/2009EP2044010A1 New pharmaceutical intermediates in the synthesis of ace- inhibitors and the use thereof
04/08/2009CN101405278A Novel heterocyclic NF-kB inhibitors
04/08/2009CN101402603A Polyhalogenated heterocycle ketene peptide derivative and synthesis thereof
04/08/2009CN100475872C Azlactone chain transfer agents for free radical polymerization
04/08/2009CN100475799C Merocyanine derivatives for cosmetic use
04/08/2009CN100475795C Heterocyclic compounds useful as nurr-1 activators
04/08/2009CN100475778C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
04/07/2009CA2490152C Oxazole derivatives and their use as insulin sensitizers
04/07/2009CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease
04/02/2009WO2009043027A2 Multi-armed forms of activated polyoxazoline and methods of synthesis thereof
04/02/2009WO2009040008A1 Novel iminooxazole and iminothiazole compounds
04/02/2009WO2009021749A3 Preparation of a compound for the treatment of duchenne muscular dystrophy
04/02/2009WO2009021748A3 Polymorphs of a compound for the treatment of duchenne muscular dystrophy
04/02/2009WO2009011880A3 Heterocyclic modulators of pkb
04/02/2009WO2008157537A3 Compositions and methods of use for treating or preventing lipid related disorders
04/02/2009US20090087376 Heterocyclic Dye Compounds For In Vivo Imaging And Diagnosis Of Alzheimer's Disease
04/01/2009EP2042492A1 Novel Iminooxazole and Iminothiazole Compounds
04/01/2009EP1755585A4 Transthyretin stabilization
04/01/2009CN101397279A Method for preparing acanthus alkaloid A with anti inflammatory and analgesic activities and derivatives thereof
04/01/2009CN101397278A Method for synthesizing 3-aryl-5-alkenyl oxazoline-2-one
03/2009
03/31/2009US7511156 Analogs of Salinosporamide A
03/31/2009US7511149 Using ruthenium tetraoxide and alkali metal permanganate
03/31/2009US7511068 antiinflammatory agents
03/31/2009US7511034 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants
03/26/2009WO2009015111A3 Process for preparing oxazolidine-and oxazolidinone-aminodiols and related intermediates
03/26/2009US20090082395 Soluble epoxide hydrolase inhibitors
03/26/2009US20090082392 Substituted Carboxylic Acids
03/26/2009US20090082345 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
03/25/2009EP2039689A1 Process for production of optically active 3-amino-2 -hydroxypropionic cyclopropylamide derivatives and salts thereof
03/25/2009EP2038265A2 Human protein tyrosine phosphatase inhibitors and methods of use
03/25/2009EP1789403B1 N-(phenyl-oxazol-4-ylmethoxymethyl)-cyclohexyl.succinic acid amide derivatives and related compounds which are used as ppar-ligands (peroxisome proliferator activated receptors) for the treatment of hyperlipidaemie and diabetes
03/25/2009CN100471838C VLA-4 inhibitors
03/24/2009US7507830 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles
03/24/2009US7507757 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
03/19/2009WO2009035951A2 Soluble epoxide hydrolase inhibitors
03/19/2009WO2008139467A3 Lipid conjugated cyclic carbonate derivatives, their synthesis, and uses
03/19/2009US20090076280 N-(benzoxazole-2-yl)-N-(3-(4-methoxyphenoxy)propyl)-3-hydroxybenzylamine dissolved in dichloromethane and triethylamine is reacted with 2-trifluoromethanesulfonyloxybutyrolactone to form (R)-2-[3-[N-(benzoxazol-2-yl)-N-(3-(4-methoxyphenoxy)propyl)aminomethyl]phenyloxy]butyrolactone
03/19/2009US20090076102 Deuterium-enriched muraglitazar
03/19/2009US20090076006 Hsp90 inhibitors containing a zinc binding moiety
03/19/2009US20090075979 CETP Inhibitors
03/19/2009US20090075938 Treatment of duchenne muscular dystrophy
03/18/2009EP2035397A1 Chemical compounds
03/18/2009EP1689380A4 Method for treating adamts-5-associated disease
03/18/2009CN101389684A Curable epoxy resin composition
03/18/2009CN101389619A Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
03/17/2009US7504515 IMPDH inhibitor useful in treating IMPDH-mediated diseases such as immune system related diseases, viral diseases, and cancers
03/17/2009US7504512 BCL-X1 protein inhibitors; anticarcinogenic agents
03/17/2009US7504426 Antiallergens; rhitinis; antiinflammatory agents
03/17/2009US7504413 N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
03/12/2009WO2009032294A2 Processes for the preparation of a linezolid intermediate, linezolid hydroxide
03/12/2009WO2009030672A1 Process for the manufacture of alkyl compounds
03/12/2009US20090069396 Polyene Oxazoles and Processes for Their Preparation
03/12/2009US20090069330 Substituted Oxazole Compounds with Analgesic Activity
03/12/2009US20090066245 Material for light-emitting element and light emitting element
03/11/2009EP2033957A1 Process for the manufacture of alkyl compounds
03/11/2009EP2033950A1 Substituted tetracycline compounds
03/11/2009EP2032546A1 Oxazole derivatives and their use in the treatment of diabetes and obesity
03/11/2009EP2032535A1 Spirocyclic nitriles as protease inhibitors
03/11/2009EP1620440B1 Synthesis of substituted heterocyclic compounds
03/11/2009CN101384563A Substituted oxazole derivatives with an analgesic action
03/11/2009CN101384532A Process for preparing optically active alcohols
03/11/2009CN100467466C Intermediate products for producing oxazolidinone-quinolone hybrids
03/11/2009CN100467456C Alpha-piperazine substituted phenyl-propionic acid derivatives as hPPAR alpha and hPPAR gamma agonist
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 210